ICC confirms anti-doping violation by Ireland women’s cricketer

Ireland women’s cricketer Rebecca Stokell has admitted breaching the International Cricket Council’s (ICC) anti-doping regulations following the detection of a prohibited substance in a sample collected from her earlier this year.

Ireland women’s cricketer Rebecca Stokell has admitted breaching the International Cricket Council’s (ICC) anti-doping regulations following the detection of a prohibited substance in a sample collected from her earlier this year.

According to the ICC a sample provided by Stokell on June 23, 2026 tested positive for a specified prohibited substance.

The cricket governing body said the anti-doping violation was linked to the use of prescribed medication. Stokell has accepted a voluntary suspension which came into effect on October 23, 2026.

The development means the Irish cricketer has acknowledged the anti-doping breach while accepting the suspension as the matter proceeds through the relevant process.

The ICC confirmed the case in an official statement but declined to provide further details while the proceedings remain unresolved.

It said no additional comments would be made until a decision had been reached in Stokell’s case.

The incident highlights the importance of compliance with anti-doping regulations in international cricket including the rules governing the use of medication by players.

Athletes are required to ensure that any medication they take does not breach anti-doping requirements. The circumstances surrounding Stokell’s case however have not been fully disclosed by the ICC.

Further information about the prohibited substance the length of the suspension and the final outcome is awaited.